Addex Therapeutics Ltd. | Income Statement
Fiscal year is January-December. All values CHF Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
707.60
110.10
25.90
25.80
15.20
-
Gross Income
707.60
110.10
25.90
25.80
15.20
-
SG&A Expense
13,893.10
2,413.10
3,406.30
3,515.60
3,719.70
8,124.40
EBIT
14,600.70
2,523.20
4,659.30
3,256.30
3,735.00
1,424.60
Non Operating Income/Expense
134.70
746.80
415.20
106.80
454.50
220.20
Pretax Income
14,461.80
1,774.90
4,204.20
3,149.40
3,280.40
1,644.80
Consolidated Net Income
14,461.80
1,774.90
4,204.20
3,149.40
3,280.40
1,644.80
Net Income
14,461.80
1,774.90
4,204.20
3,149.40
3,280.40
1,644.80
Net Income After Extraordinaries
14,461.80
1,774.90
4,204.20
3,149.40
3,280.40
1,644.80
Net Income Available to Common
14,461.80
1,774.90
4,204.20
3,149.40
3,280.40
1,644.80
EPS (Basic)
1.60
0.18
0.39
0.28
0.25
0.07
Basic Shares Outstanding
9,066.10
9,984.90
10,852.10
11,412.30
12,941.40
23,293.20
EPS (Diluted)
1.60
0.18
0.39
0.28
0.25
0.07
Diluted Shares Outstanding
9,066.10
9,984.90
10,852.10
11,412.30
12,941.40
23,293.20
EBITDA
13,893.10
2,413.10
4,633.40
3,230.50
3,719.70
1,421.70
Other Operating Expense
-
-
1,227.10
285.10
-
-
Non-Operating Interest Income
4.10
1.60
39.90
0.00
-
-
About Addex Therapeutics
View Profile
